Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes.

por Raul M Luque, Qing Lin, José Córdoba-Chacón, Papasani V Subbaiah, Thorsten Buch, Ari Waisman, Hugo Vankelecom, Rhonda D Kineman
Publicado 2011

The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells.

por Su-Chen Li, Cécile Martijn, Tao Cui, Ahmed Essaghir, Raúl M Luque, Jean-Baptiste Demoulin, Justo P Castaño, Kjell Öberg, Valeria Giandomenico
Publicado 2012

Role of endogenous cortistatin in the regulation of ghrelin system expression at pancreatic level under normal and obese conditions.

por Belén Chanclón, Raúl M Luque, José Córdoba-Chacón, Manuel D Gahete, Ana I Pozo-Salas, Justo P Castaño, Francisco Gracia-Navarro, Antonio J Martínez-Fuentes
Publicado 2013

Evolution of Metabolic Phenotypes of Obesity in Coronary Patients after 5 Years of Dietary Intervention: From the CORDIOPREV Study

por Laura Martin-Piedra, Juan F. Alcala-Diaz, Francisco M. Gutierrez-Mariscal, Antonio P. Arenas de Larriva, Juan L. Romero-Cabrera, Jose D. Torres-Peña, Javier Caballero-Villarraso, Raul M. Luque, Pablo Perez-Martinez, Jose Lopez-Miranda, Javier Delgado-Lista
Publicado 2021

The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer.

por Manel Puig-Domingo, Raúl M Luque, Jordi L Reverter, Laura M López-Sánchez, Manuel D Gahete, Michael D Culler, Gonzalo Díaz-Soto, Francisco Lomeña, Mattia Squarcia, José Luis Mate, Mireia Mora, Laureano Fernández-Cruz, Oscar Vidal, Antonio Alastrué, Jose Balibrea, Irene Halperin, Dídac Mauricio, Justo P Castaño
Publicado 2014

Impaired mRNA splicing and proteostasis in preadipocytes in obesity-related metabolic disease

por Julia Sánchez-Ceinos, Rocío Guzmán-Ruiz, Oriol Alberto Rangel-Zúñiga, Jaime López-Alcalá, Elena Moreno-Caño, Mercedes Del Río-Moreno, Juan Luis Romero-Cabrera, Pablo Pérez-Martínez, Elsa Maymo-Masip, Joan Vendrell, Sonia Fernández-Veledo, José Manuel Fernández-Real, Jurga Laurencikiene, Mikael Rydén, Antonio Membrives, Raul M Luque, José López-Miranda, María M Malagón
Publicado 2021

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

por Emilia Alors-Perez, Ricardo Blázquez-Encinas, Sonia Alcalá, Cristina Viyuela-García, Sergio Pedraza-Arevalo, Vicente Herrero-Aguayo, Juan M. Jiménez-Vacas, Andrea Mafficini, Marina E. Sánchez-Frías, María T. Cano, Fernando Abollo-Jiménez, Juan A. Marín-Sanz, Pablo Cabezas-Sainz, Rita T. Lawlor, Claudio Luchini, Laura Sánchez, Juan M. Sánchez-Hidalgo, Sebastián Ventura, Laura Martin-Hijano, Manuel D. Gahete, Aldo Scarpa, Álvaro Arjona-Sánchez, Alejandro Ibáñez-Costa, Bruno Sainz, Raúl M. Luque, Justo P. Castaño
Publicado 2021